Light-based device test for cervical cancer screening
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests a new light-based device to screen for cervical cancer. It is for people who already have abnormal screening results (like high-risk HPV and an abnormal Pap test).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a full, healthy cervix (no prior surgery that removed part of it).
- You had cervical cancer screening showing HPV 16/18 or another high-risk HPV type, and a Pap test result of ASC-US or worse.
- You have never had cervical cancer or any other cancer.
- You do not have a weak immune system, active vaginal or cervical infection, bleeding disorder, or a condition that makes you sensitive to light.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new light-based device to screen for cervical cancer. It may help find cancer earlier in people with certain HPV types or abnormal Pap tests.
This study is testing a new, non-invasive way to screen for cervical cancer. It uses a photoelectric device and an epigenetic test done on a sample from your cervix. The goal is to find early signs of cancer more accurately than current methods.
This trial is testing a new, low-cost, lab-free screening test for cervical cancer. The goal is to see if it can detect early signs of cancer without needing a doctor's visit or a lab — making it easier for women to get screened.
This study tests a light-activated therapy (HAL-PDT) to treat high-grade cervical dysplasia before considering surgery. It compares the response to standard surgery, aiming to see if the light therapy can help avoid or delay more invasive procedures.
This study tests a low-cost imaging approach during colposcopy, for people who have abnormal cervical screening results or need follow-up after prior abnormal cells. It may help clinics detect cervical changes more easily and at lower cost.
This trial tests a new way to quickly diagnose and treat cervical pre-cancer using a point-of-care device. It may help women who are HPV-positive avoid a separate treatment visit.
Hear when a new Uterine Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.